Tue, March 31, 2020
Mon, March 30, 2020
Fri, March 27, 2020
Thu, March 26, 2020
Wed, March 25, 2020

Madhu Kumar Maintained (ABUS) at Buy with Decreased Target to $4 on, Mar 27th, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-4-on-mar-27th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Madhu Kumar of Baird, Maintained "Arbutus Biopharma Corporation" (ABUS) at Buy with Decreased Target from $8 to $4 on, Mar 27th, 2020.

Madhu has made no other calls on ABUS in the last 4 months.



There are 2 other peers that have a rating on ABUS. Out of the 2 peers that are also analyzing ABUS, 0 agree with Madhu's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Madhu


  • Keay Nakae of "Chardan Capital" Upgraded from Hold to Strong Buy and Increased Target to $5 on, Friday, March 6th, 2020
  • Liisa Bayko of "JMP Securities" Upgraded from Hold to Buy and Held Target at $10 on, Wednesday, February 5th, 2020

Publication Contributing Sources